Parnassus Rebalances: Sells Salesforce Stake, Bets on Edwards Lifesciences and Old Dominion

Key Facts

1Parnassus Investments reduced its stake in Salesforce by 30.1%, selling 1,106,930 shares.

2The firm increased its investment in Edwards Lifesciences by 23.6%, bringing its total holding value to approximately $50 million.

3Parnassus Investments boosted its stake in Old Dominion Freight Line by 116% during the fourth quarter.

In a move reflecting institutional shifts away from certain software giants, Parnassus Investments LLC has executed a significant rebalancing of its investment portfolio. According to reports, the firm reduced its stake in Salesforce by 30.1%, offloading over 1.1 million shares, while increasing its position in Edwards Lifesciences by 23.6% to reach a total value of approximately $50 million. Additionally, the firm boosted its stake in Old Dominion Freight Line by a substantial 116% during the fourth quarter.

This rotation comes as the tech sector faces mixed pressures; while AI remains a growth driver, investor skepticism regarding valuations for companies like Salesforce (CRM) has grown relative to the healthcare sector. Per market data, Edwards Lifesciences (EW) is gaining traction as a defensive play, while the aggressive bet on Old Dominion (ODFL) signals institutional confidence in the U.S. logistics sector despite broader economic cycle concerns.

Traders should monitor current price levels, with CRM closing at $166.45 and EW at $85.76 (close June 11, 2026). Looking ahead, market sentiment may be influenced by upcoming U.S. Existing Home Sales data, which could provide insights into consumer strength and its impact on industrial stocks like ODFL, which closed at $247.76 on the same date.